⌘K

Home/Filings/4/0000950170-23-064564

4//SEC Filing

Western Standard LLC 4

Accession 0000950170-23-064564

CIK 0001274792other

View on SEC.gov Company Profile

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 5:09 PM ET

Size

14.4 KB

Accession

0000950170-23-064564

Insider Transaction Report

Form 4

Period: 2023-11-14

MERRIMACK PHARMACEUTICALS INCMACK

DirectorOther

Transactions

Purchase
Common Stock
2023-11-14$12.50/sh+10,887$136,088→ 459,727 total(indirect: See footnote)
Purchase
Common Stock
2023-11-14$12.50/sh+39,283$491,038→ 1,658,981 total(indirect: See footnote)

WESTERN STANDARD PARTNERS LP

Other

Transactions

Purchase
Common Stock
2023-11-14$12.50/sh+39,283$491,038→ 1,658,981 total(indirect: See footnote)
Purchase
Common Stock
2023-11-14$12.50/sh+10,887$136,088→ 459,727 total(indirect: See footnote)

Western Standard Partners QP, L.P.

Other

Transactions

Purchase
Common Stock
2023-11-14$12.50/sh+10,887$136,088→ 459,727 total(indirect: See footnote)
Purchase
Common Stock
2023-11-14$12.50/sh+39,283$491,038→ 1,658,981 total(indirect: See footnote)

Western Standard LLC

Other

Transactions

Purchase
Common Stock
2023-11-14$12.50/sh+39,283$491,038→ 1,658,981 total(indirect: See footnote)
Purchase
Common Stock
2023-11-14$12.50/sh+10,887$136,088→ 459,727 total(indirect: See footnote)

Footnotes (2)

[F1]The shares are directly held by WSP. The general partner of the Funds is Western Standard. The managing member of Western Standard and the portfolio manager to the Funds is Mr. Andersen. Each of Western Standard and Mr. Andersen disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
[F2]The shares are directly held by WSP QP. The general partner of the Funds is Western Standard. The managing member of Western Standard and the portfolio manager to the Funds is Mr. Andersen. Each of Western Standard and Mr. Andersen disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

MERRIMACK PHARMACEUTICALS INC

CIK 0001274792

Entity typeother

IncorporatedCA

Related Parties

1

filerCIK 0001517666

Filing Metadata

Form type: 4
Filed: Nov 15, 7:00 PM ET
Accepted: Nov 16, 5:09 PM ET
Size: 14.4 KB

View on SEC.gov